The role of metabotropic glutamate receptors in Alzheimer's disease

被引:0
|
作者
Lee, H
Zhu, XW
O'Neill, MJ
Webber, K
Casadesus, G
Marlatt, M
Raina, AK
Perry, G
Smith, MA
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Eli Lilly & Co, Lilly Res Ctr Ltd, Windlesham GU20 6PH, Surrey, England
关键词
Alzheimer's disease; glutamate receptor; selective neurodegeneration;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While glutamatergic transmission is severely altered by early degeneration of cortico-cortical connections and hippocampal projections in Alzheimer's disease (AD), the role of glutamate receptors in the pathogenesis of AD is not yet defined clearly. Nonetheless, as reviewed here, the topographical distribution of different types of receptors likely contributes to the regional selective nature of neuronal degeneration. In particular, metabotropic glutamate receptors (mGluR) may contribute the pathogenesis of many neurological conditions and also regulate neuronal vulnerability against cytotoxic stress. Thus, we here discuss the possible role of mGluR in the pathogenesis of AD based on the results from other neurodegenerative diseases that may give us clues to solve the mysterious selective neurodegeneration evident in AD.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 50 条
  • [21] Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease
    Reynolds, I. J.
    [J]. NEUROPHARMACOLOGY, 2008, 55 (04) : 620 - 621
  • [22] Targeting metabotropic glutamate receptors for the treatment of Parkinson's disease
    Huot, Philippe
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (04) : 203 - 206
  • [23] Huntington’s Disease and Group I Metabotropic Glutamate Receptors
    Fabiola M. Ribeiro
    Rita G. W. Pires
    Stephen S. G. Ferguson
    [J]. Molecular Neurobiology, 2011, 43 : 1 - 11
  • [24] Huntington's Disease and Group I Metabotropic Glutamate Receptors
    Ribeiro, Fabiola M.
    Pires, Rita G. W.
    Ferguson, Stephen S. G.
    [J]. MOLECULAR NEUROBIOLOGY, 2011, 43 (01) : 1 - 11
  • [25] Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease
    Amalric, Marianne
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2015, 20 : 29 - 34
  • [26] Targeting Metabotropic Glutamate Receptors (mGluRs) in Parkinson's Disease
    Amalric, M.
    [J]. CURRENT NEUROPHARMACOLOGY, 2014, 12 : 2 - 2
  • [27] Role of the metabotropic glutamate receptor on Huntington's disease
    Ribeiro, F. M.
    Anborgh, P. H.
    Cregan, T.
    Ferguson, S. S.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 198 - 198
  • [28] Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease
    Abd-Elrahman, Khaled S.
    Ferguson, Stephen S. G.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 235 - 254
  • [29] Role of Metabotropic Glutamate Receptors in Neurological Disorders
    Crupi, Rosalia
    Impellizzeri, Daniela
    Cuzzocrea, Salvatore
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [30] Role of metabotropic glutamate receptors in nicotine dependence
    Markou, A.
    [J]. NEUROPHARMACOLOGY, 2008, 55 (04) : 609 - 609